Tesamorelin Side Effects
Tesamorelin is a GHRH analogue with FDA approval for HIV-associated lipodystrophy. It is clinically well studied but requires physician monitoring for fluid balance and glucose effects, particularly in patients with pre-existing metabolic conditions.
This page is for educational purposes only and is not medical advice. Side effects vary between individuals. All protocols at Peptides Thailand are individually prescribed by licensed physicians. Contact your doctor with any concerns during treatment.
Side effects to be aware of
Injection site reactions
CommonRedness, swelling, or bruising at the injection site. Common with daily subcutaneous injections and usually mild.
Water retention or fluid accumulation
CommonGH axis stimulation can cause mild fluid retention. Patients notice this as mild puffiness or a slight increase in weight that is not fat. Usually resolves when the dose is adjusted or the protocol ends.
Joint pain or stiffness
UncommonReported by a meaningful number of patients, particularly at higher doses or in older patients. Usually mild to moderate and manageable.
Tingling or numbness
UncommonPeripheral tingling or numbness, similar to mild carpal tunnel symptoms, can occur with sustained GH axis stimulation.
Blood sugar changes
Requires monitoringGH axis stimulation can transiently affect glucose handling. Patients with pre-diabetes or diabetes require closer monitoring. The effect is generally mild compared to direct GH use.
Headache
UncommonOccasionally reported, usually mild.
Monitoring
Blood glucose monitoring is recommended, particularly for patients with pre-diabetes or risk factors for glucose intolerance. IGF-1 levels may also be assessed.
Who is a good candidate?
- Adults with visceral fat accumulation resistant to diet and exercise
- Patients with HIV-associated lipodystrophy
- Those seeking body composition improvement with a metabolic focus
- Patients with uncontrolled diabetes
- Those with active cancer
- Pregnant women
Contraindications
Your physician screens for these conditions before prescribing. Do not attempt to self-prescribe.
- Active malignancy
- Pregnancy and breastfeeding
- Uncontrolled diabetes
- Active pituitary disorders
- Severe kidney or liver disease
- Known hypersensitivity to GHRH or mannitol (a common excipient)
When to contact your physician
- Nausea, vomiting, or digestive symptoms that are severe or do not ease within two weeks
- Any chest pain, palpitations, or significant change in heart rate
- Signs of allergic reaction: rash, hives, swelling of the face or throat, or difficulty breathing
- Injection site reactions that worsen, spread, or do not resolve within 72 hours
- Any new or worsening symptoms that concern you, regardless of whether they seem related to your protocol
- Changes in any monitored values outside the range your physician specified
If you are ever unsure, contact your physician. That is what they are there for.
Learn more
Have questions about Tesamorelin?
Message our team on WhatsApp. We typically reply within minutes.
Message us on WhatsApp